CompletedPhase 3NCT02891837
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Asklepion Pharmaceuticals, LLC
- Principal Investigator
- Gurdyal Kalsi, MD, M.DAsklepion Pharmaceuticals, LLC
- Intervention
- L-citrulline(drug)
- Enrollment
- 189 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2019
Study locations (29)
- University of Alabama, Birmingham, Alabama, United States
- Loma Linda University Children's Hospital, Loma Linda, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- Arnold Palmer Hospital for Children, Orlando, Florida, United States
- Advocate Children's Hospital, Oak Lawn, Illinois, United States
- Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- St Louis University, SSM Health Cardinal Glennon Children's Hospital, St Louis, Missouri, United States
- Washington University School of Medicine/ St Louis Children's Hospital, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- The Children's Hospital at Montefiore, The Bronx, New York, United States
- +14 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02891837 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer